Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;37(3):409-418.
doi: 10.1007/s00345-018-2364-x. Epub 2018 Jun 25.

Ablation energies for focal treatment of prostate cancer

Affiliations
Review

Ablation energies for focal treatment of prostate cancer

Olivia Lodeizen et al. World J Urol. 2019 Mar.

Abstract

Context: In recent years, focal therapy has emerged as a treatment option for a selected group of men with localized prostate cancer. Cryotherapy and high-intensity focused ultrasound (HIFU) are the most investigated types of focal treatment with other options currently under evaluation.

Objective: The objective of the study was to give a comprehensive overview of six available focal treatment options for prostate cancer with their rationale, delivery mechanism, and outcomes.

Information acquisition: The SIU ICUD chapter on available Energies to Treat Prostate Cancer was used as a guide to describe the different technologies. For outcomes, a literature search was conducted using PubMed key words including focal therapy, HIFU, cryotherapy, irreversible electroporation, vascular-targeted photodynamic therapy, laser interstitial therapy, radiofrequency ablation, microwave therapy, and their synonyms in MeSH terms.

Conclusion: Focal therapy appears to have encouraging outcomes on quality of life and urinary and erectile function. For oncological outcomes, it is challenging to fully interpret the outcomes due to heterogeneity in patient selection and short-term follow-up.

Keywords: Ablation; Focal therapy; Localized; Prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

OLodeizen, Th de Reijke, M de Bruin, S Pahernik, I Varkarakis, S Crouzet and A Katz have no conflict of interest to declare. S Eggener is a consultant and advisor for Profound Medical, NxThera. J Dominguez-Escrig is principal investigator for the CROES Phase III IRE Trial. S Ghai is principal investigator for MR-guided focused ultrasound, a study sponsored by Insightec. J de la Rosette is a consultant for Angiodynamics.

Informed consent

Due to the nature of this article, acquisition of informed consent is not applicable.

Figures

Fig. 1
Fig. 1
HIFU causes vascular damage at high-intensity and cavitation at ultrahigh intensity
Fig. 2
Fig. 2
Cryotherapy causes tissue damage and vascular injury around the cryoneedle
Fig. 3
Fig. 3
Cryoneedle placement and critical distances
Fig. 4
Fig. 4
Cryotherapy stages
Fig. 5
Fig. 5
Radical oxygen causing vascular occlusion upon illumination around the fiber tips
Fig. 6
Fig. 6
Irreversible electroporation between needles causing cell death
Fig. 7
Fig. 7
Laser therapy causing thermal damage and cavitational stress, both resulting in cellular damage

References

    1. Sanda MG, Dunn RL, Michalaski J, et al. Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med. 2008;358:1250–1261. doi: 10.1056/NEJMoa074311. - DOI - PubMed
    1. Resnick MJ, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368:436–445. doi: 10.1056/NEJMoa1209978. - DOI - PMC - PubMed
    1. Bokhorst LP, et al. Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: active surveillance (PRIAS) study. BJU Int. 2016;118:366–371. doi: 10.1111/bju.13410. - DOI - PubMed
    1. Leapman MS, Carroll PR. What is the best way not to treat prostate cancer? Urol Oncol Semin Orig Investig. 2017;35:42–50. doi: 10.1016/j.urolonc.2016.09.003. - DOI - PubMed
    1. Hoffman RM, et al. Treatment decision regret among long-term survivors of localized prostate cancer: results from the prostate cancer outcomes study. J Clin Oncol. 2017;35:2306–2314. doi: 10.1200/JCO.2016.70.6317. - DOI - PMC - PubMed

MeSH terms